Venture Fund Formation

CTI Capital in its new venture capital fund

CTI Capital

Home About Us Representative Work

Expertise
Venture Fund Formation Pharmaceuticals and Life Sciences
Key Contact
Chima Ubani

Partner, Emerging and High Growth Companies, Montréal

Team
Bradley Sendel

Associate, Emerging and High Growth Companies, Montréal

 

On May 10, 2021, CTI Capital announced its new venture capital fund. The new fund includes cash from the Fonds de solidarité FTQ, Caisse de dépôt et placement du Québec (CDPQ), Investissement Québec (IQ) and Teralys Capital. CTI Capital will use this fund to invest in biotherapeutics, medial technologies and healthcare IT.

CTI Capital is a Montreal-based private venture capital fund investing in high quality emerging life science companies.

Osler, Hoskin & Harcourt LLP advised CTI Capital with a team consisting of Chima Ubani, Liliana Korosi (Emerging & High Growth Companies), and Bradley Sendel (Corporate).

Value
-
Date Closed
May 10, 2021
Lead Office
Montreal
Key Contact
Chima Ubani

Partner, Emerging and High Growth Companies, Montréal

Team
Bradley Sendel

Associate, Emerging and High Growth Companies, Montréal

RELATED EXPERTISE

Find out how we can help you achieve extraordinary results

We have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them.

Work with us

Osler is a leading business law firm practising internationally from offices across Canada and in New York. Our clients include industry and business leaders in all segments of the market and at various stages in the growth of their businesses. We have built our reputation on our commitment to our clients' success and the experience, expertise and collaborative approach for which we are recognized. We believe that our success is a reflection of our clients' success.